| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
32,246 |
24,317 |
$1.61M |
| J9271 |
Injection, pembrolizumab, 1 mg |
279 |
192 |
$1.60M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
19,152 |
10,466 |
$1.13M |
| 99215 |
Prolong outpt/office vis |
7,993 |
6,125 |
$571K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,491 |
10,656 |
$449K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
5,527 |
3,225 |
$257K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
580 |
380 |
$249K |
| J1453 |
Injection, fosaprepitant, 1 mg |
1,962 |
1,210 |
$241K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
41,663 |
29,484 |
$234K |
| 80053 |
Comprehensive metabolic panel |
27,874 |
21,735 |
$209K |
| 96367 |
|
10,333 |
5,358 |
$181K |
| J0185 |
Injection, aprepitant, 1 mg |
943 |
581 |
$179K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
12,735 |
6,620 |
$142K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,425 |
2,240 |
$126K |
| J2505 |
Injection, pegfilgrastim, 6 mg |
91 |
63 |
$122K |
| 96417 |
|
2,994 |
1,815 |
$111K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
185 |
129 |
$88K |
| 36415 |
Collection of venous blood by venipuncture |
35,168 |
26,591 |
$84K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
689 |
676 |
$58K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,552 |
602 |
$56K |
| 82728 |
|
5,029 |
4,788 |
$54K |
| J3490 |
Unclassified drugs |
597 |
294 |
$40K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,463 |
2,981 |
$32K |
| 96415 |
|
1,537 |
1,047 |
$30K |
| 83550 |
|
3,753 |
3,609 |
$26K |
| 99205 |
Prolong outpt/office vis |
267 |
252 |
$22K |
| 99222 |
Initial hospital care, per day, moderate complexity |
317 |
289 |
$21K |
| 99223 |
Prolong inpt eval add15 m |
193 |
174 |
$19K |
| 83540 |
|
3,760 |
3,617 |
$19K |
| 96411 |
|
506 |
327 |
$19K |
| 82378 |
|
1,186 |
895 |
$19K |
| 80050 |
General health panel |
340 |
294 |
$16K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
762 |
348 |
$14K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,149 |
444 |
$12K |
| 83615 |
|
2,752 |
2,453 |
$12K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
10,536 |
4,904 |
$8K |
| 86300 |
|
529 |
486 |
$8K |
| 85046 |
|
1,521 |
1,381 |
$7K |
| 96416 |
|
79 |
50 |
$5K |
| 82607 |
|
367 |
365 |
$5K |
| 96402 |
|
312 |
248 |
$5K |
| J9190 |
Injection, fluorouracil, 500 mg |
310 |
179 |
$4K |
| J3489 |
Injection, zoledronic acid, 1 mg |
153 |
128 |
$4K |
| 82784 |
|
182 |
168 |
$4K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
86 |
54 |
$3K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
110 |
41 |
$3K |
| 99442 |
|
68 |
56 |
$3K |
| 99443 |
|
45 |
36 |
$3K |
| J9267 |
Injection, paclitaxel, 1 mg |
220 |
98 |
$3K |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
978 |
429 |
$2K |
| 84165 |
|
229 |
214 |
$2K |
| 82565 |
|
441 |
319 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
814 |
300 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
129 |
121 |
$2K |
| J9045 |
Injection, carboplatin, 50 mg |
95 |
52 |
$2K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
88 |
58 |
$2K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
35 |
14 |
$872.89 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,793 |
958 |
$806.75 |
| 96368 |
|
61 |
40 |
$772.19 |
| 83883 |
|
27 |
25 |
$670.16 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
75 |
75 |
$630.12 |
| 81002 |
|
195 |
131 |
$614.47 |
| 90688 |
|
39 |
36 |
$547.58 |
| 36591 |
|
56 |
39 |
$461.44 |
| 85027 |
|
87 |
70 |
$379.31 |
| 82746 |
|
28 |
26 |
$375.92 |
| 99441 |
|
13 |
12 |
$256.33 |
| G0008 |
Administration of influenza virus vaccine |
50 |
42 |
$249.27 |
| S0028 |
Injection, famotidine, 20 mg |
462 |
221 |
$241.30 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
41 |
38 |
$210.96 |
| 84153 |
|
16 |
12 |
$210.89 |
| 90686 |
|
30 |
30 |
$175.64 |
| 83735 |
|
43 |
27 |
$13.46 |
| G9002 |
Coordinated care fee, maintenance rate |
109 |
55 |
$0.00 |
| 90662 |
|
16 |
13 |
$0.00 |
| 99233 |
Prolong inpt eval add15 m |
36 |
12 |
$0.00 |
| 86304 |
|
16 |
13 |
$0.00 |